top of page

Topic

Biomarkers

26 Podcasts • 1 Case • 2 Courses on BackTable

Exploring PARP Inhibitor Combinations in Prostate Cancer
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 71  •  07 Jul 2026

Exploring PARP Inhibitor Combinations in Prostate Cancer

With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for advanced prostate cancer? In this episode of BackTable Urology, Dr. Alan Tan is joined by Dr. Rana McKay and Dr. Emmanuel Antonarakis to discuss how evolving evidence, patient selection, timing, toxicity, and genetic testing are shaping the use of PARP inhibitor combinations in clinical practice.

This podcast is supported by an educational grant from Pfizer.

More on Biomarkers

Loading recent podcasts…

Tumor Board

Tumor Board # 71

Jul 7, 2026

with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan

Exploring PARP Inhibitor Combinations in Prostate Cancer

With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...

Tumor Board

Tumor Board # 70

Jun 30, 2026

with Dr. Chih-Yi Liao, Dr. Xavier Keutgen, Dr. Lingling Du

Diagnosis & Initial Management of Neuroendocrine Tumors

How do you unravel the complexity of diagnosing and managing neuroendocrine tumors, where every case demands a tailored...

40+ listens

Tumor Board

Tumor Board # 65

Jun 11, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

130+ listens

Urology

Urology # 307

Jun 9, 2026

with Dr. Tanya Dorff, Dr. Evan Yu, Dr. Alan Tan

Germline & Somatic Testing in Prostate Cancer Therapy

Can you really treat prostate cancer effectively without knowing the genetics? In this episode of BackTable Urology,...

900+ listens

Urology

Urology # 314

Jul 7, 2026

with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan

Exploring PARP Inhibitor Combinations in Prostate Cancer

With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...

30+ listens

Urology

Urology # 308

Jun 11, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

900+ listens

Tumor Board

Tumor Board # 64

Jun 9, 2026

with Dr. Michael Gibson, Dr. Eric Lander

Evolving Perioperative Management Strategies for Gastric & GE Junction Cancers

Is personalized, surgery-sparing treatment becoming a reality for patients with gastric adenocarcinoma? In this episode...

180+ listens

Urology

Urology # 305

Jun 2, 2026

with Dr. Sam Chang, Dr. Ruchika Talwar

Immune Therapy Innovations for BCG Unresponsive Cancer

Ready to move beyond “one-size-fits-all” for BCG-unresponsive NMIBC? In this episode of BackTable Urology, Dr. Ruchika...

1,100+ listens

Tumor Board

Tumor Board Case

Jul 13, 2026

PNET: Locally Advanced Pancreatic Neuroendocrine Tumor in Morbidly Obese Male, 10cm Mass Abutting Multiple Structures

with Dr. Chih-Yi Liao, Dr. Xavier Keutgen and Dr. Lingling Du

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page